Treatment refractory peptic ulcer omeprazole receptor antagonists controlled clinical trial hypothesis gastric H+/K+ adenosine triphosphatase inhibitor omeprazole different mode action pronounced inhibitory effect gastric acid secretion effective peptic ulcer refractory receptor antagonist treatment therapy patients duodenal ulcer prepyloric ulcer gastric ulcer mixed sites refractory peptic ulcer ulcer unhealed months treatment cimetidine daily ranitidine daily omeprazole mg daily treatment receptor antagonist dose weeks patients treatment groups 'intent analysis weeks omeprazole receptor antagonist weeks patient patients ulcers endoscopy receptor antagonist treatment weeks 